Literature DB >> 24633196

Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade.

Jon M Davison1, Haroon A Choudry2, James F Pingpank2, Steven A Ahrendt2, Matthew P Holtzman2, Amer H Zureikat2, Herbert J Zeh2, Lekshmi Ramalingam2, Benjamin Zhu1, Marina Nikiforova1, David L Bartlett2, Reetesh K Pai1.   

Abstract

Previous studies have demonstrated that the prognosis of disseminated mucinous appendiceal neoplasms is highly dependent upon tumor grade. Reflecting this, the 7th edition of the American Joint Committee on Cancer (AJCC) staging system now incorporates a three-tier grading system for prognostic staging of mucinous appendiceal tumors. However, the grading criteria are not well described. In order to address this issue, we evaluated clinicopathologic and molecular features of 219 cases from 151 patients with widely disseminated appendiceal mucinous neoplasia treated at our institution between 2004 and 2012. We identified histologic features that were associated with worse overall survival on univariate analysis: destructive invasion, high cytologic grade, high tumor cellularity, angiolymphatic invasion, perineural invasion, and signet ring cell component (all with P<0.0001). We used these morphologic characteristics to classify neoplasms into three grades: AJCC grade G1 lacked all adverse histologic features; AJCC grade G2 had at least one adverse histologic feature (except a signet ring cell component); and AJCC grade G3 were defined by the presence of a signet ring cell component. Patients with AJCC grade G2 and grade G3 adenocarcinomas had a significantly worse prognosis compared with AJCC grade G1 (P<0.0001 for each). A trend toward worse overall survival was identified for patients with AJCC grade G3 adenocarcinomas compared with AJCC grade G2 adenocarcinomas (P=0.07). Our multivariate analysis found that this three-tier grading system was a significant predictor of outcome (P=0.008), independent of other prognostic variables. After controlling for other prognostic variables, AJCC grade G2 was associated with a 2.7-fold increased risk of death (95% confidence interval (CI), 1.2-6.2) and AJCC grade G3 was associated with a 5.1-fold increased risk of death (95% CI, 1.7-14) relative to grade G1 tumors. Our results indicate that evaluation of a limited set of adverse histologic features allows for the separation of disseminated mucinous neoplasms of appendiceal origin into three morphologically defined and prognostically relevant grades as advocated by the AJCC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24633196     DOI: 10.1038/modpathol.2014.37

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  25 in total

Review 1.  Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria-What has changed and why?

Authors:  Luca Bertero; Federica Massa; Jasna Metovic; Roberto Zanetti; Isabella Castellano; Umberto Ricardi; Mauro Papotti; Paola Cassoni
Journal:  Virchows Arch       Date:  2017-12-05       Impact factor: 4.064

Review 2.  New insights in the pathology of peritoneal surface malignancy.

Authors:  Norman John Carr
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 3.  Omics analyses in peritoneal metastasis-utility in the management of peritoneal metastases from colorectal cancer and pseudomyxoma peritonei: a narrative review.

Authors:  Christin Lund-Andersen; Annette Torgunrud; Karianne Giller Fleten; Kjersti Flatmark
Journal:  J Gastrointest Oncol       Date:  2021-04

4.  Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion is Feasible and Offers Survival Benefit in Select Patients with Peritoneal Metastases.

Authors:  Haroon A Choudry; Filip Bednar; Yongli Shuai; Heather L Jones; Reetesh K Pai; James F Pingpank; Steven S Ahrendt; Matthew P Holtzman; Herbert J Zeh; David L Bartlett
Journal:  Ann Surg Oncol       Date:  2019-03-01       Impact factor: 5.344

5.  Intratumor Heterogeneity of Perfusion and Diffusion in Clear-Cell Renal Cell Carcinoma: Correlation With Tumor Cellularity.

Authors:  Qing Yuan; Payal Kapur; Yue Zhang; Yin Xi; Ingrid Carvo; Sabina Signoretti; Ivan E Dimitrov; Jeffrey A Cadeddu; Vitaly Margulis; James Brugarolas; Ananth J Madhuranthakam; Ivan Pedrosa
Journal:  Clin Genitourin Cancer       Date:  2016-04-22       Impact factor: 2.872

Review 6.  Management of Appendix Cancer.

Authors:  Kaitlyn J Kelly
Journal:  Clin Colon Rectal Surg       Date:  2015-12

Review 7.  Essentials for Pathological Evaluation of Peritoneal Surface Malignancies and Synoptic Reporting of Cytoreductive Surgery Specimens-A review and evidence-based guide.

Authors:  Aditi Bhatt; Suniti Mishra; Loma Parikh; Sandeep Sheth; Imran Gorur
Journal:  Indian J Surg Oncol       Date:  2019-03-19

8.  The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base.

Authors:  Elliot A Asare; Carolyn C Compton; Nader N Hanna; Lauren A Kosinski; Mary Kay Washington; Sanjay Kakar; Martin R Weiser; Michael J Overman
Journal:  Cancer       Date:  2015-10-27       Impact factor: 6.860

9.  Improved chemosensitivity following mucolytic therapy in patient-derived models of mucinous appendix cancer.

Authors:  Ashok K Dilly; Brendon D Honick; Robin Frederick; Anuleka Elapavaluru; Sachin Velankar; Hima Makala; T Kevin Hitchens; Lesley M Foley; Jianxia Guo; Jan H Beumer; Lora Heather Rigatti; Yong J Lee; David L Bartlett; Haroon A Choudry
Journal:  Transl Res       Date:  2020-10-22       Impact factor: 7.012

10.  Molecular profiling of appendiceal serrated lesions, polyps and mucinous neoplasms: a single-centre experience.

Authors:  Giada Munari; Gianluca Businello; Paola Mattiolo; Angelo Paolo Dei Tos; Matteo Fassan; Gianmaria Pennelli; Marta Sbaraglia; Chiara Borga; Salvatore Pucciarelli; Gaya Spolverato; Claudia Mescoli; Francesca Galuppini; Antonio Sommariva; Elena Bellan; Sara Lonardi; Fotios Loupakis; Claudio Luchini
Journal:  J Cancer Res Clin Oncol       Date:  2021-03-12       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.